Indications, side effects, contraindications and other prescribing information for Besponsa on MIMS. Inotuzumab ozogamic (Besponsa) is supplied for Tenders, Emergency imports, Un - licensed, Specials, Orphan drug, Name patient line, RLD supplies, Reference listed drugs, Comparator Drug, Bio-Similar, Innovator samples, For Clinical trials.. There was a trend in favour of BESPONSA for estimated mean postbaseline scores from the EuroQoL 5 Dimension (EQ-5D) questionnaire, (BESPONSA and Investigator's choice of chemotherapy, respectively) for the EQ-5D index (0.80 versus 0.76, minimally important difference for cancer = 0.06).. The various contributors involved in the value chain of Besponsa include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Besponsa include The key manufacturers in the Besponsa include. Besponsa Prices, Coupons and Patient Assistance Programs. Besponsa (inotuzumab ozogamicin) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Lymphoblastic Leukemia.. NICE has changed its mind and recommended regular NHS funding for Pfizer’s Besponsa blood cancer drug, after the manufacturer submitted a new analysis and cut its price..